With R&D, production and regulatory affairs all integrated on a single site we offer a complete range of CDMO services from early-stage development to scale-up & commercial manufacture of high potent APIs with occupational exposure limits (OEL) down to 0.1g/m³/shift (OEB class 5). In trusted long-term partnerships, we enable pharmaceutical and biotechnological companies to develop and provide innovative treatments of the highest quality to their patients globally. We have a proven track record in our capability to take projects from early stage through to commercial production. We operate three FDA inspected sites in France and Belgium.